News

December 29, 2016December 29, 2016

Raynaud’s Phenomenon Most Common Symptom Signaling Mixed Connective Tissue Disease

News

Raynaud’s phenomenon may signal the development of mixed connective tissue disease, as a study showed that it was the most common symptom in people who were later diagnosed with the ... Read more

December 7, 2016December 7, 2016

Revlimid May Effectively Treat Raynaud’s Phenomenon in Pediatric SLE, Study Shows

News

Revlimid (lenalidomide) was found to effectively treat skin manifestations in adolescents with systemic lupus erythematosus, including Raynaud’s phenomenon. The study, “Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus,” ... Read more

December 2, 2016December 2, 2016

Study Finds Reduced Blood Flow in Heart Tissue of Raynaud’s Patients

News

Patients with both primary and secondary Raynaud’s phenomenon have an abnormally low blood penetration in the heart tissue, which likely explains the increased death rates from heart disease in these ... Read more

November 30, 2016November 30, 2016

Extension Study Gets Underway for Resunab as Treatment for Dermatomyositis Patients

News

Corbus Pharmaceuticals is starting a one-year, open-label extension study for the ongoing Phase 2 clinical trial evaluating the effect of Resunab in patients with skin-predominant dermatomyositis – an inflammatory disease that ... Read more

November 21, 2016November 21, 2016

Cilostazol Shows Promise as Potential Oral Therapy for Raynaud’s Phenomenon in SSc Patients

News

Researchers found that the oral drug cilostazol is a potential oral therapy for ameliorating Raynaud’s phenomenon in patients with systemic sclerosis (SSc). The study “Efficacy of cilostazol for the treatment ... Read more

November 18, 2016November 18, 2016

Acupressure Fails to Benefit Raynaud’s Patients in Small Study

News

Acupressure does not appear to be an effective way of managing Raynaud’s phenomenon, according to a small clinical trial comparing the intervention to patient education. The trial (NCT01784354) also noted that accurate ... Read more

November 14, 2016November 14, 2016

Artery Block Blood Flow Measurement Tool Useful, But Can’t Discern Raynaud’s Types

News

While measures of the increase in microvessel blood flow after an artery block are abnormal in all types of Raynaud’s disease patients, the method is not sensitive enough to discriminate between ... Read more

November 9, 2016November 9, 2016

Veletri Injections Could Improve Raynaud’s Syndrome Symptoms, Review Finds

News

Intravenous Veletri (epoprostenol) injection could be efficient in treating Raynaud’s phenomenon, a literature review published in the journal Annals of Pharmacotherapy has shown. In addition, according to the study, patients ... Read more

November 7, 2016November 7, 2016

Iloprost Infusion May Slow Sclerodema Progression, Prevent Finger Ulcers in Secondary Raynaud’s Patients

News

Iloprost, a drug used for secondary Raynaud’s phenomenon, might stop the development of new ulcers in the fingers, protect against heart and lung disease, and prevent the worsening of the ... Read more

November 4, 2016November 4, 2016

Radioactive Compound Seen to Help Diagnose and Classify Raynaud’s Phenomenon

News

A radiopharmaceutical technique can be used as an objective tool to diagnose Raynaud’s phenomenon (RP) and differentiate between primary and secondary RP, according to a study published in the journal ... Read more